DeepRESP

The DeepRESP device is a Class II Electroencephalograph designed to aid in diagnosing sleep disorders by analyzing sleep study recordings to infer sleep staging and arousals. Through retrospective clinical validation, the device demonstrated non-inferiority and superiority in several aspects compared to predicate devices for severity classification, respiratory event scoring, and sleep state/arousal estimation.

The DeepRESP device, classified as an Electroencephalograph (Class II), has received a determination of substantial equivalence, permitting its marketing to aid in the diagnosis of various sleep disorders in adults aged 22 and above. Its core functionality involves analyzing sleep study recordings, with or without EEG signals, to mark events, annotate traces, calculate measures, and infer sleep staging and arousals within clinical settings. This advanced analytical capability positions DeepRESP as a significant tool for comprehensive sleep disorder assessment.Regulatory compliance for DeepRESP includes adherence to general controls such as annual registration, device listing, good manufacturing practices, and labeling standards, alongside specific requirements like the Quality System regulation and the Unique Device Identification System rule. Clinical performance studies retrospectively validated the device's ability to accurately score sleep recordings both with and without EEG, demonstrating non-inferiority and, in several aspects, superiority compared to predicate devices, particularly in severity classification, respiratory event scoring, and sleep state/arousal estimation, confirming its efficacy and safety profile for its intended diagnostic purpose.

AI Regulatory Concerns

Powered by

Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.

• Q1. What specific algorithms or AI methodologies does DeepRESP employ for inferring sleep staging and arousals, and how do these contribute to its claimed superiority?; Beyond respiratory events, what other types of sleep-related events (e.g., PLMS, seizures) can DeepRESP accurately identify and classify, and how does its performance compare for these?; Could the clinical performance studies provide more detailed statistics on the "several aspects of superiority" (e.g., AUC, sensitivity, specificity for specific event types) compared to predicate devices?; Given its ability to function without EEG signals, what are the primary non-EEG physiological parameters DeepRESP utilizes for its analysis, and what is the diagnostic utility of such analyses compared to full PSG?; What post-market surveillance plans are in place to monitor the long-term safety and effectiveness of DeepRESP, particularly concerning its performance in diverse adult populations or less common sleep disorders?